We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

44 hedge funds and large institutions have $12.2M invested in Neos Therapeutics, Inc in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 49 → 44 (-5)

16% less capital invested

Capital invested by funds: $14.6M → $12.2M (-$2.39M)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
7
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$197K
2
BCM
Bridgeway Capital Management
Texas
+$142K
3
Renaissance Technologies
Renaissance Technologies
New York
+$96.6K
4
Goldman Sachs
Goldman Sachs
New York
+$43.7K
5
Squarepoint
Squarepoint
New York
+$16.5K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.24M
2
SCM
Stonepine Capital Management
Oregon
-$193K
3
BlackRock
BlackRock
New York
-$101K
4
Wells Fargo
Wells Fargo
California
-$51.7K
5
Millennium Management
Millennium Management
New York
-$28.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$3.16M – – –
SCM
2
Stonepine Capital Management
Oregon
$3.05M -$193K -243,120 -5%
Goldman Sachs
3
Goldman Sachs
New York
$1.81M +$43.7K +55,147 +2%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.2M -$4.14K -5,221 -0.3%
SFM
5
Sphera Funds Management
Israel
$651K -$1.24M -1,559,157 -62%
Renaissance Technologies
6
Renaissance Technologies
New York
$564K +$96.6K +121,900 +17%
BlackRock
7
BlackRock
New York
$274K -$101K -127,982 -24%
Jacobs Levy Equity Management
8
Jacobs Levy Equity Management
New Jersey
$268K +$197K +248,272 +174%
BCM
9
Bridgeway Capital Management
Texas
$243K +$142K +179,500 +103%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$233K – – –
DM
11
Deerfield Management
New York
$220K – – –
BGIM
12
Brandywine Global Investment Management
Pennsylvania
$86K +$1.51K +1,900 +2%
Northern Trust
13
Northern Trust
Illinois
$83K +$390 +492 +0.4%
HAIM
14
Hunter Associates Investment Management
Pennsylvania
$69K – – –
PCM
15
Proxima Capital Management
New York
$53K -$11.2K -14,076 -15%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$27K – – –
BWM
17
BCS Wealth Management
Tennessee
$20K – – –
UBS Group
18
UBS Group
Switzerland
$18K +$14.9K +18,839 +244%
ACM
19
Allred Capital Management
Texas
$17K – – –
State Street
20
State Street
Massachusetts
$17K – – –
William Blair & Company
21
William Blair & Company
Illinois
$16K -$3.17K -4,000 -15%
SCM
22
Southport Capital Management
Tennessee
$16K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$15K -$1.83K -2,306 -9%
Charles Schwab
24
Charles Schwab
California
$15K – – –
Squarepoint
25
Squarepoint
New York
$14K +$16.5K +20,774 New
1
2

NEOS Hedge Fund Activity: Q2 2020 in Review

44 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2020, worth a combined $12.2M — down 16% from $14.6M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NEOS and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $197K. The largest seller was Sphera Funds Management, cutting an estimated $1.24M.

  • 44 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2020, down from 49 in Q1 2020.
  • Funds reported $12.2M of Neos Therapeutics, Inc stock for Q2 2020, down 16% quarter-over-quarter.
  • 2 funds opened new Neos Therapeutics, Inc positions in Q2 2020 and 6 closed out, a net change of -4 holders.
  • The largest Neos Therapeutics, Inc buyer in Q2 2020 was Jacobs Levy Equity Management, an estimated $197K added.
  • The largest Neos Therapeutics, Inc seller in Q2 2020 was Sphera Funds Management, an estimated $1.24M sold.

Based on aggregated 13F filings for Q2 2020.